Rubius Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$13.9M

191 transactions

Summary

Rubius Therapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $7.3MSales: $5.7M30 insiders

Date	Insider	Type	Value
2022-08-10	Appelhans Dannielle(Chief Operating Officer)	Sell	$5K
2023-02-01	CAGNONI PABLO J	Sell	$2K
2023-01-31	CAGNONI PABLO J	Sell	$2K
2023-02-24	Appelhans Dannielle(CEO and President)	Sell	$1K
2023-02-01	Appelhans Dannielle(CEO and President)	Sell	$969.5
2023-01-31	Turka Laurence A.(Chief Scientific Officer)	Sell	$622.32
2023-01-31	Turka Laurence A.(Chief Scientific Officer)	M	$0
2023-01-31	Turka Laurence A.(Chief Scientific Officer)	M	—
2023-01-31	CAGNONI PABLO J	M	$0
2023-01-31	CAGNONI PABLO J	M	—
2023-01-31	Appelhans Dannielle(CEO and President)	M	$0
2023-01-31	Appelhans Dannielle(CEO and President)	M	—
2023-01-29	Turka Laurence A.(Chief Scientific Officer)	M	$0
2023-01-29	Turka Laurence A.(Chief Scientific Officer)	M	—
2023-01-29	CAGNONI PABLO J	M	$0
2023-01-29	CAGNONI PABLO J	M	—
2022-08-09	Appelhans Dannielle(Chief Operating Officer)	M	$0
2022-08-09	Appelhans Dannielle(Chief Operating Officer)	M	—
2022-07-29	Schaffert Susanne	A	$0
2022-05-12	Epstein David R	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Rubius Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope